It also involved in activation, chemotaxis, and cytotoxicity of leukemia cells in the TME, and a number of studies have reported that the prognosis of AML patients with upregulated ITGAM expression was poor [28]. This evidence concerns the gene ITGAM and acute myeloid leukemia.